Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,898 | -16,871 | -33,811 | -21,450 | -11,982 |
| Depreciation Amortization | 54 | 22 | 51 | 35 | 22 |
| Accounts payable and accrued liabilities | 2,760 | 343 | 441 | -6 | -385 |
| Other Working Capital | 837 | 470 | 4,079 | 1,727 | 449 |
| Other Operating Activity | 5,198 | 1,430 | 2,198 | 1,319 | 1,007 |
| Operating Cash Flow | $-33,049 | $-14,606 | $-27,042 | $-18,375 | $-10,889 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181 | -110 | -128 | -83 | -5 |
| Investing Cash Flow | $-181 | $-110 | $-128 | $-83 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 130,156 | 147 | 96,295 | 96,294 | 2 |
| Other Financing Activity | -458 | -35 | 50,575 | 50,825 | 51,953 |
| Financing Cash Flow | $129,698 | $112 | $146,870 | $147,119 | $51,955 |
| Beginning Cash Position | 127,766 | 127,766 | 8,066 | 8,066 | 8,066 |
| End Cash Position | 224,234 | 113,162 | 127,766 | 136,727 | 49,127 |
| Net Cash Flow | $96,468 | $-14,604 | $119,700 | $128,661 | $41,061 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,049 | -14,606 | -27,042 | -18,375 | -10,889 |
| Capital Expenditure | -181 | -110 | -128 | -83 | -5 |
| Free Cash Flow | -33,230 | -14,716 | -27,170 | -18,458 | -10,894 |